Live from the NIH registry
Studies recruiting near Allentown right now
Top 25 of 229 recruiting studies, sorted by proximity — each links to its official registry page
The PREDICT Registry:
DCIS, Stage 0 Breast Cancer
N/A
Observational 3,000 participants sought
St Luke's University Health Network — Easton, Pennsylvania (14.8 mi)
· Sponsor: PreludeDx
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
St. Luke's University Health Network — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Nectero Medical, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Epithelial Ovarian Cancer, Primary Peritoneal
Phase 2
Interventional 230 participants sought
SCRI - Alliance Cancer Specialists, PC — Doylestown, Pennsylvania (26.8 mi)
· Sponsor: TORL Biotherapeutics, LLC
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
St. Luke's University Health Network — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Hoffmann-La Roche
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Bipolar Disorder, Bipolar Depression
Phase 3
Interventional 400 participants sought
Lehigh Center for Clinical Research — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Xenon Pharmaceuticals Inc.
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
St. Luke's University Health Network ( Site 0017) — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing ANSOS for Efficacy in Multi-Tribal Urban Communities
Smokeless Tobacco Cessation
N/A
Interventional 384 participants sought
Lehigh University — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Lehigh University
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Phase 3
Interventional 450 participants sought
Alliance Cancer Specialists — Sellersville, Pennsylvania (19.0 mi)
· Sponsor: Nuvalent Inc.
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
Aneurysm, Dissection
N/A
Observational 2,000 participants sought
Lehigh Valley Hospital — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Vascutek Ltd.
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - Unk041 — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Mirati Therapeutics Inc.
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
St. Luke's University Health Network — Easton, Pennsylvania (14.8 mi)
· Sponsor: Regeneron Pharmaceuticals
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Medtronic
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.
Arthritis, Unstable Radial Head
N/A
Interventional 84 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Aptis Medical
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Mid Atlantic Retina (Site 050) — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: EyeBiotech Ltd.
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Medtronic
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Lehigh Valley Hospital - Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: American Society of Clinical Oncology
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Children's Oncology Group
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 410 participants sought
Local Institution - 1019 — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Pan Tumor Rollover Study
Cancer
Phase 2
Interventional 1,500 participants sought
Local Institution - 0037 — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Bristol-Myers Squibb
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Endometrial Cancer, Endometrioid Adenocarcinoma
N/A
Observational 1,715 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: PedAL BCU, LLC
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Wake Forest University Health Sciences